Carol Meschter, DVM, PhD, DACVP
Chief Executive Officer

Dr. Carol Meschter is one of the original founders of Comparative Biosciences. Previously, she was in the Investigative Toxicology Group at Hoffmann-LaRoche in Nutley, N.J., and was the director of the Research Animal Facility at the American Health Foundation in Valhalla, N.Y. As a board-certified veterinary pathologist, Dr. Meschter brings 20 years of experience in the pharmaceutical industry, primarily in toxicology, pathology, preclinical development, discovery support and preclinical pharmacology. Knowledgeable about early-phase drug development from discovery to new drug application, she has technical expertise in pathology, pharmacology, efficacy modeling and pharmacokinetics. Dr. Meschter is a scientific editorial reviewer for Toxicologic Pathology, Veterinary Pathology, AVMA Journal, AJVR, J Applied Immunology and has over 100 publications.

Fariba Chalajour, MD, MBA
Managing Director

Dr. Chalajour joined the GBG team in 2020. As the Managing Director of Comparative Biosciences, Inc, a GLP preclinical CRO based in California, she manages the company’s operations, ensures high-quality preclinical studies, and provides strategic leadership in animal study design and to the histopathology team. By combining her business acumen with her 20 years of experience in experimental medicine and translational research, she fosters collaborative relationships with clients and stakeholders to successfully meet their project needs and regulatory requirements.

Prior to her current role, Dr. Chalajour held the position of VP of Preclinical Histopathology at Comparative Biosciences, Inc. In this role, she oversaw scientific and operational activities related to histopathology projects and formulated business objectives. She also managed the sales and marketing activities and developed client relationship management strategies. She was promoted to Managing Director in 2022.

Dr. Chalajour earned her medical degree from Azad University Medical School in Tehran, Iran. Her residency training was focused on cardiovascular surgery at University Heart and Vascular Center in Hamburg, Germany. Following this, she completed her research fellowship in cardiothoracic surgery at Stanford University Medical Center. Throughout her career, Dr. Chalajour has contributed to scientific literature and presented her research findings at conferences. She has been involved in multiple peer-reviewed articles and worked as a consultant to various pharmaceutical and medical device companies.